Wechselwirkungen · Lumeblue (previously Methylthioninium chloride Cosmo)
Lumeblue 25 mg prolonged-release tablets · Abschnitt 4.5 · PDF-Seite 4
HOS-220126 · Präparat HOS-216547
Serious central nervous system (CNS) reactions have been recorded when methylthioninium chloride was administered via intravenous use to patients taking certain psychiatric medicinal products (see section 4.4). Reported cases occurred in patients taking specific serotonergic psychiatric medicinal products, namely a selective serotonin reuptake inhibitor (SSRI), a serotonin-norepinephrine reuptake inhibitor (SNRI), monoaminooxidase inhibitors or clomipramine. It is not known if there is a risk of serotonin syndrome when methylthioninium chloride is administered orally in preparation for colonoscopy.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
RxNorm-Namen im Text (wörtliche Treffer, Rolle nicht bewertet): norepinephrine (HOS-090547) serotonin (HOS-085477) clomipramine (HOS-085906)
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-06-17T16:40:00Z · SHA-256 621188d5f64a4490fe97b9da8aa94ea37b740fe8ff7b61603be8af2b1f01a404 · Passage 30d13ab25e0598760198126ebcd1d72bb4f402436c4cc00eab7b9031ae2131a2 · Zeichen 159–764 im Abschnitt